Клинички испитувања за ХОБП во Alabama
21 студии за ХОБП бараат учесници на локации во Alabama.
Градови во Alabama
Официјален текст на студијата (англиски)
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Cullman
- Research Site, Mobile
Се регрутираФаза 3
Возраст од 40 до 80 · Сите полови · Ажурирано 2.10.2026 · NCT06283966Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- University of Alabama at Birmingham- Site Number : 8400003, Birmingham
- Pulmonary Associates - Mobile- Site Number : 8400151, Mobile
Се регрутираФаза 3
Возраст од 40 до 80 · Сите полови · Ажурирано 1.10.2026 · NCT07190222A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- University of Alabama at Birmingham, Birmingham
Се регрутираФаза 2
Возраст од 40 до 75 · Сите полови · Ажурирано 25.9.2026 · NCT07759245A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
- University of Alabama at Birmingham - School of Medicine- Site Number : 8400003, Birmingham
Се регрутираФаза 4
Возраст од 40 до 85 · Сите полови · Ажурирано 22.9.2026 · NCT07053423A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Birmingham
Се регрутираФаза 2
Возраст 40 и постари · Сите полови · Ажурирано 9.9.2026 · NCT07082738Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- University of Alabama, Birmingham
Се регрутираФаза 2
Возраст 40 и постари · Сите полови · Ажурирано 4.9.2026 · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Cullman
Се регрутираФаза 3
Возраст од 40 до 80 · Сите полови · Ажурирано 3.9.2026 · NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Foley
- Research Site, Mobile
- Research Site, Sheffield
Се регрутираФаза 3
Возраст од 40 до 80 · Сите полови · Ажурирано 3.9.2026 · NCT06883305A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
- University of Alabama at Birmingham, Birmingham
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 2.9.2026 · NCT06603246A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- University of Alabama at Birmingham Lung Health Center, Birmingham
- SEC Clinical Research, Dothan
- Pulmonary Associates of Mobile, P.C., Mobile
Се регрутираФаза 2/3
Возраст од 35 до 80 · Сите полови · Ажурирано 31.8.2026 · NCT07363694A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 106, Birmingham
Се регрутираФаза 3
Возраст од 18 до 80 · Сите полови · Ажурирано 11.8.2026 · NCT07555483Improving Patient-Centered Care for Underserved Older African American Patients With Cardiovascular Comorbidities
- Cooper Green Mercy Hospital, Birmingham
Се регрутираНабљудувачка студија
Возраст од 50 до 99 · Сите полови · Ажурирано 6.8.2026 · NCT07748858Multi-Center Clean Air Randomized Controlled Trial in COPD
- University of Alabama, Lung Health Center, Birmingham
Се регрутираФаза 3
Возраст 40 и постари · Сите полови · Ажурирано 31.7.2026 · NCT06376994Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital
- The University of Alabama at Birmingham, Birmingham
Се регрутира
Возраст 22 и постари · Сите полови · Ажурирано 23.6.2026 · NCT07222410SPIROMICS Study of Early COPD Progression (SOURCE)
- University of Alabama at Birmingham, Birmingham
Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери
Возраст од 30 до 55 · Сите полови · Ажурирано 3.6.2026 · NCT05033990Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
- University of Alabama-Birmingham Hospital - UAB Lung Health Center, Birmingham
Се регрутира
Возраст од 40 до 80 · Сите полови · Ажурирано 28.4.2026 · NCT07051707Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
- University of Alabama at Birmingham, Birmingham
Се регрутира
Возраст од 40 до 84 · Сите полови · Ажурирано 24.4.2026 · NCT06891755Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Sheffield
Се регрутираФаза 3
Возраст од 40 до 80 · Сите полови · Ажурирано 9.4.2026 · NCT06961214PiMZ Longitudinal Cohort (PiMZ Logic)
- University of Alabama at Birmingham, Birmingham
Се регрутираНабљудувачка студија
Возраст 18 и постари · Сите полови · Ажурирано 16.1.2026 · NCT06505603Genetic Variation in IgG in Alpha 1 Antitrypsin Deficiency
- University of Alabama at Birmingham, Birmingham
Се регрутираФаза 4
Возраст 19 и постари · Сите полови · Ажурирано 10.11.2025 · NCT07135427myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
- UAB School of Medicine/Lung Health Center, Birmingham
Се регрутира
Возраст 30 и постари · Сите полови · Ажурирано 6.2.2025 · NCT05204888Од ClinicalTrials.gov, податоци преземени 5.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.